Hypermutability in clinical isolates of Klebsiella pneumoniae is uncommon and is unrelated to ciprofloxacin resistance

International Journal of Antimicrobial Agents

Volumn 36, Issue 3, 2010, Pages 239-242

  Aathithan, S ^a   French, G L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Enterobacteriaceae; Fluoroquinolone resistance; Klebsiella; Random hypermutation

Indexed keywords

CIPROFLOXACIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; PROTEIN PARC; RIFAMPICIN; STREPTOMYCIN; ANTIINFECTIVE AGENT; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA STRUCTURE; EPSILOMETER TEST; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS; UNITED KINGDOM; GENETICS; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MUTATION;

ANTI-BACTERIAL AGENTS; CIPROFLOXACIN; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LONDON; MICROBIAL SENSITIVITY TESTS; MUTATION; RIFAMPIN; STREPTOMYCIN;

EID: 77954952871     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.04.010     Document Type: Article

References (15)

1. Bridges B.A. Hypermutation in bacteria and other cellular systems. Philos Trans R Soc Lond B Biol Sci 2001, 356:29-39.
2. Chopra I., O'Neill A.J., Miller K. The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist Updat 2003, 6:137-145.
3. Hall L.M.C., Henderson-Begg S.K. Hypermutable bacteria isolated from humans-a critical analysis. Microbiology 2006, 152:2505-2514.
4. Oliver A., Canton R., Campo P., Baquero F., Blazquez J. High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 2000, 288:1251-1253.
5. Modrich P. Methyl-directed DNA mismatch correction. J Biol Chem 1989, 264:6597-6600.
6. LeClerc J.E., Li B., Payne W.L., Cebula T.A. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 1996, 274:1208-1211.
7. Blazquez J. Hypermutation as a factor contributing to the acquisition of antimicrobial resistance. Clin Infect Dis 2003, 37:1201-1209.
8. Barbosa T.M., Levy S.B. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J Bacteriol 2000, 182:3467-3474.
9. Gutierrez O., Juan C., Perez J.L., Oliver A. Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients. Antimicrob Agents Chemother 2004, 48:3573-3575.
10. Landman D., Bratu S., Kochar S., Panwar M., Trehan M., Doymaz M., et al. Evolution of antimicrobial resistance among Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae in Brooklyn, NY. J Antimicrob Chemother 2007, 60:78-82.
11. Hooper D.C. Mechanisms of quinolone resistance. Quinolone antimicrobial agents 2003, 41-67. ASM Press, Washington, DC. D.C. Hooper, E. Rubinstein (Eds.).
12. Aathithan S. Mechanisms and genetics of ciprofloxacin resistance in Klebsiella pneumoniae. PhD Thesis. London, UK: University of London; 2008.
13. Phillips I., Culebras E., Moreno F., Baquero F. Induction of the SOS response by new 4-quinolones. J Antimicrob Chemother 1987, 20:631-638.
14. Luo N., Sahin O., Lin J., Michel L.O., Zhang Q. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump. Antimicrob Agents Chemother 2003, 47:390-394.
15. Maciá M.D., Borrell N., Perez J.L., Oliver A. Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion. Antimicrob Agents Chemother 2004, 48:2665-2672.